TrialPanorama/Dataset huggingface dataset:
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: In-hospital Physiotherapy for Patients Undergoing Thoracic Surgery - a Randomized Controlled Trial
Brief Summary: Lung cancer is one of the most common types of cancer in the world, and the cancer that causes the most number of deaths. In Sweden, about 3700 persons are diagnosed every year. About one fifth of the patients are eligible for surgery.

Patients undergoing thoracic surgery suffer from pain and low health related quality of life after surgery.

In Australia, New Zealand, and the United Kingdom, pre- and postoperative physiotherapy is routinely provided for patients undergoing thoracic surgery, but the effects have not been thoroughly investigated. The scientific evidence of the effect of physiotherapy in connection with lung surgery is limited. The treatment typically consists of early mobilisation, breathing exercises and exercises for the shoulders. Reeve et al has shown that a postoperative shoulder exercise program can improve function and decrease pain after thoracotomy. Breathing exercises has not been found effective in reducing the rate of postoperative pulmonary complications after thoracic surgery.

The purpose of this study is to investigate the effect of in-hospital physiotherapy treatment, for patients undergoing thoracic surgery, on physical activity, health related quality of life, pain and lung function.


Options:
A: Arm Label: rehabilitation; Type: EXPERIMENTAL; Interventions: Other: Rehabilitation | Arm Label: usual care; Type: SHAM_COMPARATOR; Interventions: Other: Usual care | Intervention Type: OTHER; Name: Rehabilitation; Assigned to Arm(s): rehabilitation | Intervention Type: OTHER; Name: Usual care; Assigned to Arm(s): usual care
B: Arm Label: Physiotherapy; Type: EXPERIMENTAL; Interventions: Other: Physiotherapy | Arm Label: Control group; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: OTHER; Name: Physiotherapy; Assigned to Arm(s): Physiotherapy
C: Arm Label: Rehabilitation Group; Type: EXPERIMENTAL; Interventions: Behavioral: Pulmonary Rehabilitation Program | Arm Label: Control Group; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Pulmonary Rehabilitation Program; Assigned to Arm(s): Rehabilitation Group
D: Arm Label: Prehabilitation group; Type: EXPERIMENTAL; Interventions: Behavioral: Trimodal prehabilitation management | Arm Label: Control group; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Trimodal prehabilitation management; Assigned to Arm(s): Prehabilitation group

Answer: B
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Citrate Versus Heparin for the Lock of Non-tunneled Hemodialysis Catheters in Patients Hospitalised in ICU = Multicentre, Controlled, Randomised Superiority Trial
Brief Summary: After obtaining written informed consent and inclusion, patients will be randomised into 2 groups for the type of dialysis catheter lock:

* The first group will have a citrate lock
* The second group will have a heparin lock Patients will be stratified according to the centre and type of Renal Replacement Therapy (RRT) continuous or intermittent.

The daily surveillance of patients will not be different from the usual surveillance of patients on Renal Replacement Therapy.

The hemodialysis catheters used will be specific Renal Replacement Therapy catheters.

The decision to withdraw the catheter will be made by the investigator and based on clinical criteria (complications related to the catheter, termination of Renal Replacement Therapy...)


Options:
A: Arm Label: 1 prostacyclin group; Type: ACTIVE_COMPARATOR; Interventions: Drug: prostacyclin | Arm Label: 2 heparin group; Type: ACTIVE_COMPARATOR; Interventions: Drug: heparin | Intervention Type: DRUG; Name: prostacyclin; Assigned to Arm(s): 1 prostacyclin group | Intervention Type: DRUG; Name: heparin; Assigned to Arm(s): 2 heparin group
B: Arm Label: hemofiltration at 4L/h; Type: ACTIVE_COMPARATOR; Interventions: Procedure: CVVH 4 to 2 L/h | Arm Label: hemofiltration at 2L/h; Type: ACTIVE_COMPARATOR; Interventions: Procedure: CVVH 2 to 4L/h | Intervention Type: PROCEDURE; Name: CVVH 4 to 2 L/h; Assigned to Arm(s): hemofiltration at 4L/h | Intervention Type: PROCEDURE; Name: CVVH 2 to 4L/h; Assigned to Arm(s): hemofiltration at 2L/h
C: Arm Label: Heparin lock; Type: PLACEBO_COMPARATOR; Interventions: Drug: unfractionated heparin | Arm Label: Citrate lock; Type: EXPERIMENTAL; Interventions: Drug: Citrate 4% | Intervention Type: DRUG; Name: Citrate 4%; Assigned to Arm(s): Citrate lock | Intervention Type: DRUG; Name: unfractionated heparin; Assigned to Arm(s): Heparin lock
D: Arm Label: heparin; Type: ACTIVE_COMPARATOR; Interventions: Other: regional anticoagulation with citrate | Arm Label: Citrate; Type: ACTIVE_COMPARATOR; Interventions: Other: HfCitPre | Intervention Type: OTHER; Name: regional anticoagulation with citrate; Assigned to Arm(s): heparin | Intervention Type: OTHER; Name: HfCitPre; Assigned to Arm(s): Citrate

Answer: C
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Citrate Versus Heparin for the Lock of Non-tunneled Hemodialysis Catheters in Patients Hospitalised in ICU = Multicentre, Controlled, Randomised Superiority Trial
Brief Summary: After obtaining written informed consent and inclusion, patients will be randomised into 2 groups for the type of dialysis catheter lock:

* The first group will have a citrate lock
* The second group will have a heparin lock Patients will be stratified according to the centre and type of Renal Replacement Therapy (RRT) continuous or intermittent.

The daily surveillance of patients will not be different from the usual surveillance of patients on Renal Replacement Therapy.

The hemodialysis catheters used will be specific Renal Replacement Therapy catheters.

The decision to withdraw the catheter will be made by the investigator and based on clinical criteria (complications related to the catheter, termination of Renal Replacement Therapy...)


Options:
A: Arm Label: PR1; Type: ACTIVE_COMPARATOR; Interventions: Drug: Argatroban | Arm Label: PR2; Type: ACTIVE_COMPARATOR; Interventions: Drug: Lepirudin | Intervention Type: DRUG; Name: Argatroban; Assigned to Arm(s): PR1 | Intervention Type: DRUG; Name: Lepirudin; Assigned to Arm(s): PR2
B: Arm Label: RCA Group; Type: EXPERIMENTAL; Interventions: Drug: Anticoagulation to prevent clotting of the extracorporeal circuit. (regional citrate anticoagulation) | Arm Label: Heparin group; Type: EXPERIMENTAL; Interventions: Drug: Anticoagulation to prevent clotting of the extracorporeal circuit (Unfractionated heparin) | Intervention Type: DRUG; Name: Anticoagulation to prevent clotting of the extracorporeal circuit. (regional citrate anticoagulation); Assigned to Arm(s): RCA Group | Intervention Type: DRUG; Name: Anticoagulation to prevent clotting of the extracorporeal circuit (Unfractionated heparin); Assigned to Arm(s): Heparin group
C: Arm Label: Heparin lock; Type: PLACEBO_COMPARATOR; Interventions: Drug: unfractionated heparin | Arm Label: Citrate lock; Type: EXPERIMENTAL; Interventions: Drug: Citrate 4% | Intervention Type: DRUG; Name: Citrate 4%; Assigned to Arm(s): Citrate lock | Intervention Type: DRUG; Name: unfractionated heparin; Assigned to Arm(s): Heparin lock
D: Arm Label: heparin; Type: ACTIVE_COMPARATOR; Interventions: Other: regional anticoagulation with citrate | Arm Label: Citrate; Type: ACTIVE_COMPARATOR; Interventions: Other: HfCitPre | Intervention Type: OTHER; Name: regional anticoagulation with citrate; Assigned to Arm(s): heparin | Intervention Type: OTHER; Name: HfCitPre; Assigned to Arm(s): Citrate

Answer: C
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Citrate Versus Heparin for the Lock of Non-tunneled Hemodialysis Catheters in Patients Hospitalised in ICU = Multicentre, Controlled, Randomised Superiority Trial
Brief Summary: After obtaining written informed consent and inclusion, patients will be randomised into 2 groups for the type of dialysis catheter lock:

* The first group will have a citrate lock
* The second group will have a heparin lock Patients will be stratified according to the centre and type of Renal Replacement Therapy (RRT) continuous or intermittent.

The daily surveillance of patients will not be different from the usual surveillance of patients on Renal Replacement Therapy.

The hemodialysis catheters used will be specific Renal Replacement Therapy catheters.

The decision to withdraw the catheter will be made by the investigator and based on clinical criteria (complications related to the catheter, termination of Renal Replacement Therapy...)


Options:
A: Arm Label: Standard Anticoagulation; Type: ACTIVE_COMPARATOR; Interventions: Drug: Unfractionated heparin | Arm Label: Citrasate; Type: EXPERIMENTAL; Interventions: Drug: Citrasate | Intervention Type: DRUG; Name: Unfractionated heparin; Assigned to Arm(s): Standard Anticoagulation | Intervention Type: DRUG; Name: Citrasate; Assigned to Arm(s): Citrasate
B: Arm Label: M100; Type: ACTIVE_COMPARATOR; Interventions: Drug: Anticoagulation with nafamostat mesilate | Arm Label: HF1000; Type: EXPERIMENTAL; Interventions: Drug: Anticoagulation with nafamostat mesilate | Intervention Type: DRUG; Name: Anticoagulation with nafamostat mesilate; Assigned to Arm(s): HF1000, M100
C: Arm Label: Nafamostat mesilate group; Type: ACTIVE_COMPARATOR; Interventions: Drug: Nafamostat mesilate | Arm Label: No anticoagulation group; Type: PLACEBO_COMPARATOR; Interventions: Drug: Normal saline | Intervention Type: DRUG; Name: Nafamostat mesilate; Assigned to Arm(s): Nafamostat mesilate group | Intervention Type: DRUG; Name: Normal saline; Assigned to Arm(s): No anticoagulation group
D: Arm Label: Heparin lock; Type: PLACEBO_COMPARATOR; Interventions: Drug: unfractionated heparin | Arm Label: Citrate lock; Type: EXPERIMENTAL; Interventions: Drug: Citrate 4% | Intervention Type: DRUG; Name: Citrate 4%; Assigned to Arm(s): Citrate lock | Intervention Type: DRUG; Name: unfractionated heparin; Assigned to Arm(s): Heparin lock

Answer: D
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Mother Infant Retention for Health: Evaluation of a Multicomponent Strategy to Link and Retain Newly Identified HIV-infected Pregnant Women and Their Infants Throughout the Antenatal and Post-partum Period
Brief Summary: Linking HIV-infected pregnant women into prevention of mother to child transmission (PMTCT) services and keeping them in care is important in ensuring that both mother and infant beneﬁt from interventions that improve maternal health and decrease HIV transmission to infants. We propose an evaluation of strategies to link newly diagnosed HIV-infected women to care and keep them in care during pregnancy and after delivery in our study called MIR4HEALTH. The study will be conducted in Nyanza Province, Kenya. All participants will provide informed consent and will be randomized to receive the intervention, including individualized patient education, adherence support and phone call/Short Message Service (SMS) reminders for clinic appointments, or the standard of care (no additional intervention services).


Options:
A: Arm Label: Standard HIV Care Arm; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: Peer Navigation Arm; Type: EXPERIMENTAL; Interventions: Behavioral: Peer Navigation Arm | Intervention Type: BEHAVIORAL; Name: Peer Navigation Arm; Assigned to Arm(s): Peer Navigation Arm
B: Arm Label: Standard of Care; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: Study Intervention for Retention (APFU); Type: EXPERIMENTAL; Interventions: Behavioral: Study Intervention for Retention (APFU) | Intervention Type: BEHAVIORAL; Name: Study Intervention for Retention (APFU); Assigned to Arm(s): Study Intervention for Retention (APFU)
C: Arm Label: Lifestyle counseling; Type: EXPERIMENTAL; Interventions: Behavioral: Cognitive behavior therapy (CBT) | Intervention Type: BEHAVIORAL; Name: Cognitive behavior therapy (CBT); Assigned to Arm(s): Lifestyle counseling
D: Arm Label: Control; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: Community Health Workers; Type: EXPERIMENTAL; Interventions: Behavioral: community health workers | Intervention Type: BEHAVIORAL; Name: community health workers; Assigned to Arm(s): Community Health Workers

Answer: B
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Fetal Copeptin After Oxytocin Challenge Test
Brief Summary: The relationship of uterine contractions on fetal copeptin levels in umbilical cord blood is studied.


Options:
A: Arm Label: intravenous & intramuscular oxytocin; Type: EXPERIMENTAL; Interventions: Procedure: after delivery of the fetus & when anterior shoulder seen | Arm Label: after delivery & when anterior shoulder seen; Type: ACTIVE_COMPARATOR; Interventions: Drug: intravenous & intramuscular oxytocin | Intervention Type: DRUG; Name: intravenous & intramuscular oxytocin; Assigned to Arm(s): after delivery & when anterior shoulder seen | Intervention Type: PROCEDURE; Name: after delivery of the fetus & when anterior shoulder seen; Assigned to Arm(s): intravenous & intramuscular oxytocin
B: Intervention Type: DRUG; Name: Methyl-Ergonovine-Oxytocin; Assigned to Arm(s): N/A | Intervention Type: DRUG; Name: Oxytocin; Assigned to Arm(s): N/A
C: Arm Label: TXA; Type: EXPERIMENTAL; Interventions: Drug: Tranexamic Acid | Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo | Intervention Type: DRUG; Name: Tranexamic Acid; Assigned to Arm(s): TXA | Intervention Type: DRUG; Name: Placebo; Assigned to Arm(s): Placebo
D: Arm Label: OCT-group; Type: N/A; Interventions: N/A | Arm Label: None-OCT-group; Type: N/A; Interventions: N/A

Answer: D
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Implementing Technology-Assisted Drug Treatment and Relapse Prevention in Federally Qualified Health Centers (FQHCs)
Brief Summary: Implementing a mobile-phone based system for drug use disorders in primary care settings.


Options:
A: Arm Label: Standard HIV Care Arm; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: Peer Navigation Arm; Type: EXPERIMENTAL; Interventions: Behavioral: Peer Navigation Arm | Intervention Type: BEHAVIORAL; Name: Peer Navigation Arm; Assigned to Arm(s): Peer Navigation Arm
B: Arm Label: Interactive computer-assisted screening; Type: EXPERIMENTAL; Interventions: Behavioral: Interactive computer-assisted screening (iCAS) | Arm Label: Usual Care; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Interactive computer-assisted screening (iCAS); Assigned to Arm(s): Interactive computer-assisted screening
C: Arm Label: Seva; Type: EXPERIMENTAL; Interventions: Behavioral: Seva | Intervention Type: BEHAVIORAL; Name: Seva; Assigned to Arm(s): Seva
D: Arm Label: Standard IPV Assessment; Type: EXPERIMENTAL; Interventions: Behavioral: Standard IPV Assessment | Arm Label: Standard DOVE intervention; Type: EXPERIMENTAL; Interventions: Behavioral: Standard IPV Assessment, Behavioral: Standard DOVE Intervention | Intervention Type: BEHAVIORAL; Name: Standard IPV Assessment; Assigned to Arm(s): Standard DOVE intervention, Standard IPV Assessment | Intervention Type: BEHAVIORAL; Name: Standard DOVE Intervention; Assigned to Arm(s): Standard DOVE intervention

Answer: C
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: N/A
Brief Summary: The aim of this study is to evaluate the potential benefits in implantation, clinical pregnancy and live birth rates by an endometrial biopsy prior to an IVF/ICSI treatment. Including a follow up on possible pregnancy complications and data on children at birth.

Further it is planned to aspirate secretions from the uterus and take blood samples during the treatment, which presumably can provide information about the mechanisms underlying the possible effect of the treatment.


Options:
A: Arm Label: Endometrial Injury; Type: ACTIVE_COMPARATOR; Interventions: Other: Endometrial Injury | Arm Label: Luteal Phase Support; Type: ACTIVE_COMPARATOR; Interventions: Drug: progesterone (Crinone® %8 vaginal progesterone gel) | Arm Label: Control group; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: OTHER; Name: Endometrial Injury; Assigned to Arm(s): Endometrial Injury | Intervention Type: DRUG; Name: progesterone (Crinone® %8 vaginal progesterone gel); Assigned to Arm(s): Luteal Phase Support
B: Arm Label: Control; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: Intervention; Type: EXPERIMENTAL; Interventions: Other: Endometrial biopsy | Intervention Type: OTHER; Name: Endometrial biopsy; Assigned to Arm(s): Intervention
C: Arm Label: Endometrial Biopsy; Type: EXPERIMENTAL; Interventions: Device: Endometrial Biopsy | Arm Label: Without Biopsy; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: DEVICE; Name: Endometrial Biopsy; Assigned to Arm(s): Endometrial Biopsy
D: Arm Label: Control; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: Intervention; Type: EXPERIMENTAL; Interventions: Procedure: Office-hysteroscopy with biopsy | Intervention Type: PROCEDURE; Name: Office-hysteroscopy with biopsy; Assigned to Arm(s): Intervention

Answer: B
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Effectiveness of a Preoperative Pulmonary Rehabilitation Program in Exercise Tolerance and Quality of Life in Patients Awaiting Lung Resection by Video-assisted Thoracic Surgery
Brief Summary: The purpose of this study is to establish the effectiveness of a preoperative pulmonary rehabilitation program in patients awaiting lung resection for lung cancer by Video-assisted thoracic surgery in order to improve exercise tolerance and quality of life. The investigators hypothesized that a pulmonary rehabilitation program including both endurance and strength training may improve exercise tolerance and quality of life measured with a submaximal exercise test and a quality of life questionnaire respectively.


Options:
A: Arm Label: Exercise and whole grain rye; Type: EXPERIMENTAL; Interventions: Behavioral: Exercise, Behavioral: Whole grain rye, Behavioral: Recommendations | Arm Label: No prescriptions; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Recommendations | Intervention Type: BEHAVIORAL; Name: Exercise; Assigned to Arm(s): Exercise and whole grain rye | Intervention Type: BEHAVIORAL; Name: Whole grain rye; Assigned to Arm(s): Exercise and whole grain rye | Intervention Type: BEHAVIORAL; Name: Recommendations; Assigned to Arm(s): Exercise and whole grain rye, No prescriptions
B: Arm Label: Rehabilitation Group; Type: EXPERIMENTAL; Interventions: Behavioral: Pulmonary Rehabilitation Program | Arm Label: Control Group; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Pulmonary Rehabilitation Program; Assigned to Arm(s): Rehabilitation Group
C: Arm Label: 1; Type: EXPERIMENTAL; Interventions: Behavioral: Physical exercise | Arm Label: 2; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Physical exercise | Arm Label: 3; Type: EXPERIMENTAL; Interventions: Behavioral: Physical exercise | Intervention Type: BEHAVIORAL; Name: Physical exercise; Assigned to Arm(s): 1, 2, 3
D: Intervention Type: BEHAVIORAL; Name: exercise intervention; Assigned to Arm(s): N/A | Intervention Type: GENETIC; Name: gene expression analysis; Assigned to Arm(s): N/A | Intervention Type: GENETIC; Name: polymerase chain reaction; Assigned to Arm(s): N/A | Intervention Type: GENETIC; Name: proteomic profiling; Assigned to Arm(s): N/A | Intervention Type: GENETIC; Name: reverse transcriptase-polymerase chain reaction; Assigned to Arm(s): N/A | Intervention Type: OTHER; Name: laboratory biomarker analysis; Assigned to Arm(s): N/A | Intervention Type: OTHER; Name: medical chart review; Assigned to Arm(s): N/A | Intervention Type: OTHER; Name: questionnaire administration; Assigned to Arm(s): N/A | Intervention Type: PROCEDURE; Name: psychosocial assessment and care; Assigned to Arm(s): N/A | Intervention Type: PROCEDURE; Name: quality-of-life assessment; Assigned to Arm(s): N/A | Intervention Type: PROCEDURE; Name: support group therapy; Assigned to Arm(s): N/A | Intervention Type: PROCEDURE; Name: therapeutic dietary intervention; Assigned to Arm(s): N/A

Answer: B
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Effectiveness of a Preoperative Pulmonary Rehabilitation Program in Exercise Tolerance and Quality of Life in Patients Awaiting Lung Resection by Video-assisted Thoracic Surgery
Brief Summary: The purpose of this study is to establish the effectiveness of a preoperative pulmonary rehabilitation program in patients awaiting lung resection for lung cancer by Video-assisted thoracic surgery in order to improve exercise tolerance and quality of life. The investigators hypothesized that a pulmonary rehabilitation program including both endurance and strength training may improve exercise tolerance and quality of life measured with a submaximal exercise test and a quality of life questionnaire respectively.


Options:
A: Arm Label: Prehabilitation group; Type: EXPERIMENTAL; Interventions: Behavioral: Trimodal prehabilitation management | Arm Label: Control group; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Trimodal prehabilitation management; Assigned to Arm(s): Prehabilitation group
B: Arm Label: Rehabilitation Group; Type: EXPERIMENTAL; Interventions: Behavioral: Pulmonary Rehabilitation Program | Arm Label: Control Group; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Pulmonary Rehabilitation Program; Assigned to Arm(s): Rehabilitation Group
C: Arm Label: rehabilitation; Type: EXPERIMENTAL; Interventions: Other: Rehabilitation | Arm Label: usual care; Type: SHAM_COMPARATOR; Interventions: Other: Usual care | Intervention Type: OTHER; Name: Rehabilitation; Assigned to Arm(s): rehabilitation | Intervention Type: OTHER; Name: Usual care; Assigned to Arm(s): usual care
D: Arm Label: Physiotherapy; Type: EXPERIMENTAL; Interventions: Other: Physiotherapy | Arm Label: Control group; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: OTHER; Name: Physiotherapy; Assigned to Arm(s): Physiotherapy

Answer: B
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: A Prospective Trial of the Copper T380 IUD or Oral Levonorgestrel and the Levonorgestrel IUD Initiated With Emergency Contraception
Brief Summary: The purpose of this study is to see how often women who come to a family planning clinic for emergency contraception, the morning after pill, are willing to use either the copper IUD or the levonorgestrel IUD. The investigators will also see if pregnancies occur in those choosing the levonorgestrel IUD and if people continue to use the IUD for 1 year.


Options:
A: Arm Label: Counseling for LAM; Type: ACTIVE_COMPARATOR; Interventions: Drug: Counseling for LAM+ LNG-EC | Arm Label: Counseling for LAM+ LNG-EC; Type: EXPERIMENTAL; Interventions: Drug: Counseling for LAM+ LNG-EC | Intervention Type: DRUG; Name: Counseling for LAM+ LNG-EC; Assigned to Arm(s): Counseling for LAM, Counseling for LAM+ LNG-EC
B: Intervention Type: DRUG; Name: CDB-2914; Assigned to Arm(s): N/A | Intervention Type: DRUG; Name: levonorgestrel; Assigned to Arm(s): N/A
C: Arm Label: Copper IUD; Type: N/A; Interventions: Drug: Copper IUD | Arm Label: Levonorgestrel IUD; Type: N/A; Interventions: Drug: Levonorgestrel IUD | Intervention Type: DRUG; Name: Copper IUD; Assigned to Arm(s): Copper IUD | Intervention Type: DRUG; Name: Levonorgestrel IUD; Assigned to Arm(s): Levonorgestrel IUD
D: Intervention Type: BEHAVIORAL; Name: Increased access to emergency contraceptive pills; Assigned to Arm(s): N/A

Answer: C